CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to VRNA

Ensifentrine Dose 1

Phase 2
VERONA PHARMA (VRNA)

Phase 2

Development Phase

0

Upcoming Catalysts

0

Historical Events

1

Regulatory Approvals

No Catalysts Found

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Coronavirus Infection

View Full Landscape
Drug Information

Target Indication

Coronavirus Infection

Clinical Trial

NCT04527471

Last updated: 12/13/2025

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Regulatory Approvals
EMAPending

Ohtuvayre

Maintenance treatment in symptomatic adult patients with chronic obstructive pulmonary disease (COPD).

View on EMA
Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.